Company Filing History:
2 out of 4 
2 out of 1,743 
2 out of 5,072 
Years Active: 2021-2023
Title: Clément Geoffroy: Innovator in ERK Kinase Inhibitors
Introduction
Clément Geoffroy is a notable inventor based in Vergeze, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that act as inhibitors of ERK kinase activity.
Latest Patents
Geoffroy holds two patents that focus on azaindole derivatives and their use as ERK kinase inhibitors. The first patent describes a compound of formula (I) or its pharmaceutically acceptable salts, specifically designed to inhibit ERK kinase activity, particularly ERK2 activity. This invention also includes prodrugs of these compounds. The second patent similarly addresses zaindole derivatives and their application as ERK kinase inhibitors, again detailing a compound of formula (I) and its pharmaceutically acceptable salts for the same purpose.
Career Highlights
Throughout his career, Clément Geoffroy has worked with prominent organizations such as Agv Discovery and the Institut National de la Santé et de la Recherche Médicale. His work has been pivotal in advancing the understanding and treatment of diseases related to ERK kinase activity.
Collaborations
Geoffroy has collaborated with esteemed colleagues, including Jean-François Guichou and Cédric Bories. These partnerships have fostered innovation and contributed to the successful development of his patented compounds.
Conclusion
Cl